Zaffer Merchant (CEO) has over 25 years of working experience in the Wireless Industry specializing in the Architecture, Design and Development of Embedded Wireless Handheld Devices for Cellular, Enterprise, 2-way Paging and Public Safety Markets. His subject matter expertise includes Speech/Signal Processing & Multimedia Architectures. Zaffer is the author of several Motorola internal technical reports. Zaffer Merchant has been recognized for his many contributions at Motorola including being named Motorola Fellow, Dan Noble Fellow, Science Advisory Board Associate (SABA) and Distinguished Innovator with 19 US Patents and several pending.

Dr. John G. Harris (CTO) is an Professor at Department of Electrical and Computer Engineering with affiliate appointment in Biomedical Engineering, University of Florida, Gainesville . Dr. John Harris has over 25 years of experience in the areas of machine and human processing of language, natural language processing, speech recognition, speech synthesis, with special focus on Bio-inspired Algorithms and Hybrid DSP/Analog Systems. Over the years he has single handedly commercialized multiple speech technologies through partnership with Motorola Inc. and Texas instruments.

Dr. Makarand Jawadekar has over 27 years of experience with Pfizer Inc. (Includes R & D and Worldwide Pharmaceutical organization). R & D areas include heading Drug Delivery research & development, Clinical Trials Supply Manufacturing and Packaging, Scale-up and Technology Transfer as well as Pharmacy (CMC) areas. He managed several functions/groups within Pharmaceutical R&D for many years. He was responsible for Drug Delivery Technology Assessment function involving external ‘Drug Delivery’ technologies. He has extensive experience in creating and cultivating external partnerships and alliances for drug delivery technologies for Pfizer Global R & D. In the recent past, he had been also been engaged in coordinating outsourcing R & D activities with external partners/service providers. He began his professional career at Pfizer Central Research in early 1982, after having completed his Ph.D. in Pharmaceutics at the University of Minnesota.

Dr. Dale Williams has over 20 years of direct experience in the area of Communication disorders and speech-language pathology. He has specific experience in thoroughly understanding the pathology behind stuttering and behavioral clinical therapy. He received his PhD in Speech-language pathology from Southern Illinois University in 1992. He is currently a professor in the Dept of Communication Sciences & Disorders at Florida Atlantic University, and has a license in Speech-Language Pathology and Certificate of Clinical Competence in Speech-Language Pathology. Dr. Williams is an author of “Stuttering recovery: Personal and Empirical Perspectives”. He has over 20 publications and over 10 peer-reviewed publications.

Dr. William Harmon M.D., is the Director of Pediatric Cardiology and Pediatric Cardiac Intensive Care at the University of Miami/Holtz children‘s hospital, who for the past 18 years has been engaged in practicing cardiology. Dr. Harmon has over 20 journal publications, over 8 books and is listed in Best Doctors in America.